Skip to content
Home/Companies/Biotech/Geno

Geno

Biotech·United States·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Geno?

Geno is an American Biotech company, currently owned by Novo Holdings since 2021.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Bioindustrial Investments · 1999 · Buyout

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Novo Holdings Bioindustrial Investments

Other portfolio companies in the same fund.

Elo Life Systems
Active
AgTechUS· 2022
21st.BIO
Active
BiotechDenmark· 2021
AMSilk
Active
BiotechGermany· 2021
Bactolife
Active
BiotechDenmark· 2021
Esco Aster
Active
FoodTechSingapore· 2021
Zencore Biologics
Active
BiotechUS· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Geno?

Geno is currently owned by Novo Holdings, through Novo Holdings Bioindustrial Investments, since 2021.

When did Novo Holdings acquire Geno?

Novo Holdings acquired Geno in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue